Literature DB >> 9890753

Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine.

C M Hardy1, K J Mobbs.   

Abstract

Recombinant mouse sp56 protein was produced for testing as an antigen in an immunocontraceptive vaccine. The coding sequence for the mature sp56 protein was cloned into the bacterial expression system pFLAG using a PCR-based method on mouse testis cDNA. Polyclonal antisera were raised in mice against affinity purified recombinant sp56 fusion protein (sp56FLAG) or an artificial sp56 peptide fused to a carrier protein (KLH) and shown to cross-react to a protein band of 75 kD in detergent extracts of mouse sperm by Western immunoblot analysis under reducing conditions. The antisera to sp56FLAG also immunolocalized over the entire acrosome of mouse sperm. Female BALB/c mice were immunized intraperitoneally with sp56FLAG in a fertility trial with 20 microg sp56FLAG in Freund's Complete Adjuvant and boosted three to five times with 20 microg sp56FLAG in Freund's Incomplete Adjuvant. Litter sizes of sp56FLAG-treated mice were significantly smaller than control-treated animals after five boosts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890753     DOI: 10.1002/(SICI)1098-2795(199902)52:2<216::AID-MRD13>3.0.CO;2-R

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  9 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 2.  Antisperm contraceptive vaccines: where we are and where we are going?

Authors:  Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2011-04-11       Impact factor: 3.886

Review 3.  Contraceptive vaccines.

Authors:  Rajesh K Naz
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Status of contraceptive vaccines.

Authors:  Rajesh K Naz
Journal:  Am J Reprod Immunol       Date:  2009-01       Impact factor: 3.886

Review 5.  Development of genetically engineered human sperm immunocontraceptives.

Authors:  Rajesh K Naz
Journal:  J Reprod Immunol       Date:  2009-10-23       Impact factor: 4.054

Review 6.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

Review 7.  Vaccines for immunological control of fertility.

Authors:  Satish K Gupta; Pankaj Bansal
Journal:  Reprod Med Biol       Date:  2009-12-01

Review 8.  Immunocontraceptives: new approaches to fertility control.

Authors:  Kiranjeet Kaur; Vijay Prabha
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

Review 9.  Immunocontraceptives: How far from reality?

Authors:  Seema Lekhwani; Nd Vaswani; Veena Singh Ghalaut; Vijay Shanker; Ragini Singh
Journal:  Adv Biomed Res       Date:  2014-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.